Toronto Dominion Bank’s AngioDynamics ANGO Stock Holding History

Toronto Dominion Bank’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4	Closed	–	–	1316
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1404
2021 Q4	$0	Buy	+4	New	+$110	﹤0.01%	1500

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Toronto Dominion Bank's ANGO Position: Q2 2022 in Review

Toronto Dominion Bank sold out of AngioDynamics (ANGO) in Q2 2022, closing a stake of 4 shares.

Toronto Dominion Bank first reported a position in ANGO in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 134 funds tracked by Wall St. Rank hold ANGO as of Q2 2022.

Toronto Dominion Bank reported no remaining AngioDynamics position as of Q2 2022 after selling out during the quarter.
Toronto Dominion Bank sold 4 AngioDynamics shares in Q2 2022.
Toronto Dominion Bank first reported a position in AngioDynamics in Q4 2021 and held it in 2 quarters.
Toronto Dominion Bank's AngioDynamics position peaked at $0 in Q1 2022.
134 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.